
Kreton Mavromatis MD
Interventional Cardiology
Professor, Medicine, Emory University School of Medicine
Join to view full profile
1365 Clifton Rd NEAtlanta, GA 30322
Phone+1 404-778-5299
Fax+1 404-778-5490
Dr. Mavromatis is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Kreton Mavromatis is a cardiologist located in Atlanta, GA with subspecialties in structural heart disease and interventional cardiology. He received his education from the University of Michigan Medical School, completing his fellowship in Cardiovascular Disease at Emory University School of Medicine. He is currently the Director of the Cardiac Catheterization Laboratory at the Atlanta Veterans Affairs Medical Center. His experience includes coronary artery disease, valvular heart disease, aortic stenosis, cardiac catheterization, and coronary angiography. His publications cover various aspects of cardiac disease and intervention, and he has led several clinical trials. He is recognized as a Fellow by the American College of Cardiology.
Education & Training
Emory University School of MedicineFellowship, Cardiovascular Disease, 1997 - 2001
University of WashingtonResidency, Internal Medicine, 1994 - 1997
University of Michigan Medical SchoolClass of 1993
Certifications & Licensure
GA State Medical License 1997 - 2027
American Board of Internal Medicine Cardiovascular Disease
American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Clinical Trials
Publications & Presentations
PubMed
- Completeness of revascularization in coronary three-vessel disease and outcomes in the FAME 3 trial.Hisao Otsuki, Kuniaki Takahashi, Yuhei Kobayashi, Frederik M Zimmermann, Mohamed El Farissi
European Heart Journal. 2026-08-31 - Residual Angina Following Complete Revascularization in the ISCHEMIA Trial: Frequency, Clinical Characteristics, Health Status, and Cardiovascular Outcomes.Ayesha Singh, David L Brown, Phillip G Jones, Zhuxuan Fu, Harmony R Reynolds
Journal of the American Heart Association. 2026-05-19 - 7 citationsFractional flow reserve-guided percutaneous coronary intervention versus medical therapy for stable coronary artery disease: long-term results of the FAME 2 trial.Carlos Collet, Thabo Mahendiran, William F Fearon, Takuya Mizukami, Daniel Munhoz
Nature Medicine. 2026-01-01
Press Mentions
Cath Lab Attire: ‘Dress up and Shut Up’ or Time for a Change?March 28th, 2025
In ISCHEMIA Population, Invasive Group Benefits from Complete RevascularizationJune 16th, 2021
NCDR Study Examines Link Between MR and Mortality, Rehab in TAVR PatientsJanuary 11th, 2018
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: